Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Research Collaboration with Boston Children’s Hospital

SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
September 18, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Participate in September Conferences

SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
September 04, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at the H.C. Wainwright 21st Annual Global Investment Conference

SAN DIEGO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel...
August 14, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Second Quarter 2019 Results and Provides Corporate Update

aTyr to report interim safety results from Phase 1b/2a proof-of-concept trial of ATYR1923 in pulmonary sarcoidosis patients in Q4 2019 Company to host conference call and webcast today, August...
August 07, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Announce Second Quarter 2019 Results on August 14th

SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
August 06, 2019 08:00 ET | Source: aTyr Pharma, Inc.

Leading Immunobiology Researcher Dr. David Briscoe Joins aTyr Pharma as Scientific Advisor

SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines, today announced the...
July 10, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Host Key Opinion Leader Call and Webcast on Sarcoidosis and the Current Treatment Landscape

SAN DIEGO, July 10, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
July 01, 2019 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Strengthens Board of Directors with the Appointment of Two New Members

SAN DIEGO, July 01, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
June 28, 2019 16:05 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Reverse Stock Split to Regain NASDAQ Compliance

SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
May 13, 2019 16:05 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces First Quarter 2019 Results and Provides Corporate Update

Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients ongoing Advanced lead position in Neuropilin-2 (NRP-2) biology with inaugural NRP-2 summit Company to host...